• FR
  • EN
  • JP
  • News
  • Careers
  • Contact Us
Menu

Oncodesign innovation vector.

Oncodesign
  • About
  • Offerings
  • Innovation model
  • Technologies
  • Investors
 

News

  • News
  • Upcoming events
  • Webinars
  • Scientific publications
    • Papers
      • Papers 2012-2017
      • Papers 2006-2011
      • Papers 2002-2005
      • Papers 1999-2001
      • Papers 1995-1998
      • Papers 1988-1994
    • Posters
      • Posters & Presentations 2020
      • Posters & Presentations 2019
      • Posters & Presentations 2018
      • Posters 2017
      • Posters 2016
      • Posters 2015
      • Posters 2014
      • Posters 2013
      • Posters 2012
      • Posters 2011
      • Posters 2010
      • Posters 2009
      • Posters 2008
      • Posters 2007
      • Posters 2006
      • Posters 2004-2005
      • Posters 2000-2003
  1. Home
  2. News
  3. [Congress] Infectious Diseases Virtual Partnering - 2-4 December 2020

Tweets by OncodesignSA

[Congress] Infectious Diseases Virtual Partnering - 2-4 December 2020

[Congress] Infectious Diseases Virtual Partnering - 2-4 December 2020

Oncodesign is engaged and committed to help finding therapeutic solutions and innovative treatments against pandemic COVID-19 disease.
We offer solutions to evaluate innovative preventive and therapeutic strategies both on COVID-19 infection but also on its associated complications, such as cytokine storm or lung fibrosis in Acute Respiratory Distress Syndrome!

Discover our in vitro and in vivo models:

  • In vitro models: cell and biochemical assays
  • In vivo models: non-human primates and Golden Syrian hamster

Our team will unveil our continuum of specialties to unlock the scientific padlocks linked to COVID-19.

I schedule a meeting with Emily, Nicolas and Christophe!

I want to know more!

About Oncodesign
  • Vision
  • Our mission
  • Key figures
  • Management
  • Scientific Advisory Board
  • Where to find us
Offerings
  • Services
  • Partnerships 
  • Licensing
  • Therapeutic areas & Experimental models
Our innovation model
  • Etiology
  • Discovery
  • Experimentation
Our technologies
  • Nanocyclix®
  • T.O.T.
  • PREDICT®
  • Chi-mice®
  • Pharmimage®
  • OncoSNIPE®
Investors
  • A word from the Chairman
  • Financial calendar
  • Shares
  • Documentation
  • Sign up for email alerts
  • Investors contacts
Carreers
  • Our values
  • Job offers/work-study arrangements
  • Internships
  • Spontaneous applications
News
  • Upcoming events
  • Webinars
  • Scientific publications
Contact
  • Contact us
  • Sales team
logo AFSII
logo AAALAC

Personal Data PolicyLegal noticeContact Us

(C) copyright Oncodesign - all right reserved

20 rue Jean Mazen | B.P. 27627 | 21076 Dijon Cedex | France | Tel.+33 (0)3.80.78.82.60 | Fax +33 (0)3.80.78.82.61

Newsletter- en

Subscribe to the general newsletter

Invalid Input

Invalid Input

Invalid Input

Subscribe to the Investor Alert

Oncodesign